Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Nations for Youngsters to Visit - 2Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech
- 3Figure out How to Analyze Medical attendant Compensation Patterns Across Different Specializations
- 4Europe could get 42 more days of summer by the year 2100 due to climate change
- 5Ancient mass grave discovered in water cistern during Tel Azekah excavations
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Flight cancellations: Full list of 40 airports hit by FAA cuts amid government shutdown
- Brazil passes anti-gang law allowing seized crypto to fund security forces
- AfD in Brandenburg takes back suit against the intelligence service
- Scientists document a death from a meat allergy tied to certain ticks
- Treasure trove found in Egyptian tomb solves ancient mystery
- Police investigate Lahav 433 officer accused of sexually harassing subordinate policewoman
- Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- Turkey, Egypt, Qatar discuss second phase of Gaza ceasefire deal
